• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DePuy Synthes

Medtech stories we missed this week: April 27, 2018

April 27, 2018 By Danielle Kirsh

canyon at sunset

From DuPuy Synthes’s spinal implant launch to Lumendi’s FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. DePuy Synthes launches spinal implants DePuy Synthes announced in an April 26 press release that it has launched its Proti 360º integrated titanium family of interbody devices that are designed to […]

Filed Under: Featured, Food & Drug Administration (FDA), Hematology, Hospital Care, Orthopedics, Regulatory/Compliance Tagged With: abbott, apolloendosurgery, Cerus Corp., DePuy Synthes, lumendi, PAVmed, reshapelifesciences, sanquin

The 11 most innovative medical devices of 2017

October 19, 2017 By Danielle Kirsh

The nominees for the best medical technology of 2017 were recently announced for the 11th Annual Prix Galien USA Awards. The Galien Foundation, the host of the awards, hands out the Prix Galien Award annually to examples of outstanding biomedical and technology product achievement designed to improve human condition. Before candidates can qualify for the […]

Filed Under: Cardiovascular, Diabetes, Diagnostics, Featured, Hematology, Hospital Care, Imaging, Neurological, Oncology, Patient Monitoring, Research & Development, Surgical, Wound Care Tagged With: abbott, Allergan, Biosense Webster, Boston Scientific, BrainScope, DePuy Synthes, Ethicon, INSIGHTEC, Integra LifeSciences, johnsonandjohnson, Koning Corporation, medtech

Orthocell, J&J’s DePuy Synthes ink R&D deal for stem cell treatment

January 12, 2017 By Sarah Faulkner

Orthocell (ASX:OCC) said today that it landed a research collaboration deal with Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes for its Ortho-ATI stem cell regenerative therapy. The 2 groups are planning a collaborative study for the 1st quarter in 2017, led by Allan Wang from the University of Western Australia. In previous studies, Ortho-ATI has proven […]

Filed Under: Featured, Regenerative Medicine, Research & Development, Stem Cells, Wall Street Beat Tagged With: DePuy Synthes, johnsonandjohnson, Orthocell

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS